Featured

Global Point of Care (PoC) Lipid Test Market to Witness 4.34% Growth during 2022

Global Point of Care (PoC) Lipid Test Market to Witness 4.34% Growth during 2022
Written by Publishing Team

PUNE, India, March 9, 2022 /PRNewswire/ — The global point of care (PoC) lipid test market was valued at US$ 260.48 Mn in 2021 and is estimated to grow at a CAGR of 4.34% over the forecast period (2022 – 2030), according to the newly published report by Absolute Markets Insights. The growing prevalence of target diseases such as cardiovascular disease, diabetes, and dyslipidemia, as well as the changing nature of the medical sector, is driving the global point of care (PoC) lipid test market. Moreover, growing geriatric population across developed and developing crops is also contributing towards the market growth. Points of care (PoC) tests are medical tests that aid in the diagnosis of a problem in the human body at a specific point. PoC testing has several advantages, including the elimination of sample transportation to the central laboratory, a simple analytic process, a small sample requirement (eg, only a drop of blood), and very quick availability of results (1–2 minutes). Increased investments by major companies to develop technologically advanced point of care (PoC) lipid test devices are expected to drive the growth of Global Point of Care (PoC) Lipid Test Market during the forecast period. For example, Abbott’s Cholestech Ldx Analyzer is designed to deliver accurate, actionable, and easily accessible results that have become an industry standard in point-of-care lipid profile, cholesterol, and glucose testing. It provides data for immediate risk assessment and therapeutic monitoring of cardiovascular disease and diabetes.

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1082

Global Point of Care (PoC) Lipid Test Market Research Scope:

Base Year

2021

Historic Years

2015 – 2020

Forecast Years

2022 – 2030

Segments Covered

Offering, Disease Indication, End Users

Quantitative Units

Revenue in USD million/billion (2015 – 2030) and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Rest of North America, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America

Companies Profiled

Abaxis, A Menarini Diagnostics srl, Abbott, EuroMedix, F. Hoffmann-La Roche Ltd, iXensor, Nova Biomedical, PTS Diagnostics, SD Biosensor, INC, Siemens Healthcare GmbH and other market participants

Report Coverage

Market Determinants and Influencing Factors, Macro-Economic and Micro-Economic Indicators, Market Dynamics (Drivers, Restraints, Opportunities

Challenges), Trends, Exclusive Details on the Effect of the Pandemic, Porter’s Five Forces Analysis, Competitor Profiles and Landscape, Company Market Share Analysis, Product Benchmarking

Customization Scope

We offer the feasibility of customizing the reports specific to regions which will cover exclusive insights on regions and its respective countries (namely North America, Europe, Asia Pacific, Middle East & Africa, Latin America)

Add-Ons

We offer our report in different languages ​​which include German, French, Spanish, Japanese and Korean amongst others.

Point of Care (PoC) Lipid Test Consumables are estimated to witness Fastest Growth over the Forecast Period

Consumable of the PoC lipid test include test strips, cassette, and others. Point of care (PoC) has the potential to provide rapid blood and other critical care test results in close proximity to the patient. The test strip provides rapid test results and has the potential to improve patient care. Hospitals and specialty centers require regular supply of these consumables to ensure seamless operations and cater to the patients in a timely and efficient manner, which is majorly fueling the segment’s growth in the global point of care (PoC) lipid test market.

Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1082

Point of Care (PoC) Lipid Test to Gain Traction for Liver and Renal Diseases and Diabetes Mellitus over the Forecast Period

Rising cases of chronic diseases such as liver and renal diseases, as well as diabetes, are expected to contribute to the growth of global point of care (PoC) lipid test market over the forecast period. The leading cause of death among patients with chronic kidney disease is cardiovascular disease (CVD). One of the most significant pathophysiological for CVD in CKD patients is the widespread and possibly increased formation of atherosclerotic plaques owing to hyperlipidemia, uremic toxins, inflammation, and endothelial dysfunction. According to the US Department of Health and Human Services, chronic kidney disease (CKD) affects more than one in every seven adults in the United States or about 37 million people. The risk of CKD is even higher for people who have diabetes or high blood pressure, the two most common causes of kidney disease. Kidney disease affects nearly one-third of people with diabetes and one-fifth of people with high blood pressure.

Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1082

The Impact of COVID-19 Pandemic on the Global Point of Care (PoC) Lipid Test Market

The World Health Organization (WHO) declared a pandemic of a novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in March 2020. When COVID-19 cases began to rise worldwide, experts identified that the virus was especially dangerous for people with heart disease and related conditions, particularly for patients with high blood pressure. Telecommunication and internet technologies have been adopted to ensure seamless transformation of information in the required time. Patient portals were among one of the methods of connecting physicians with patients, who may be quarantined or working from home. The results of home testing devices could be downloaded into the patient’s medical record on these portals for review by the physician. Point of care (PoC) testing devices are becoming a more popular method of providing laboratory testing close to the patient with a quick turnaround of test results. Healthcare delivery is evolving to better meet the needs of patients. Initiatives by companies to adapt more seamlessly to changing market conditions showcases positive growth prospects for the global point of care (PoC) lipid test market over the forecast period.

View our exclusive press releases on Industry Global News24

North America dominated the Global Point of Care (PoC) Lipid Test Market in 2021

According to the global figures, in 2021, North America accounted for the highest share in the global point of care (PoC) lipid test market. Countries such as the United States, Canadaand Mexico have made significant technology investments and are implementing advanced medical devices in the healthcare industry. Furthermore, the region’s high number of patients with cardiovascular diseases, combined with the advanced medical infrastructure, contributes to the market growth. In order to produce high-quality products, manufacturers in this region are focusing on product development as well as the incorporation of advanced technologies, which is will fuel the market growth over the period of the next eight years.

The key market participants operating in the global point of care (PoC) lipid test market are:

  • Axis
  • PTS Diagnostics
  • A Menarini Diagnostics srl
  • Abbott
  • EuroMedix
  • F. Hoffmann-La Roche Ltd
  • iXensor
  • Nova Biomedical
  • SD Biosensor, INC
  • Siemens Healthcare GmbH
  • Other Market Participants

Purchase the latest in-depth Global Point of Care (PoC) Lipid Test Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1082

Global Point of Care (POC) Lipid Test Market:

  • By offering
    • Instruments
    • Consumables
      • Test Strips
      • Cassette
      • Others
  • By Disease Indication
    • Lipid and Lipoprotein Disorders
      • Hyperlipidemia
      • Hypertriglyceridemia
      • Familial Hypercholesterolemia
      • Hyperlipoproteinemia
      • Others
    • Atherosclerosis
    • Liver and Renal Diseases
    • Diabetes Mellitus
    • Others
  • By End Users
    • Hospitals
    • Physician Offices and Clinics
    • Others
  • By Region
    • North America
      • US
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • France
      • The UK
      • Spain
      • Germany
      • Italy
      • Nordic Countries
        • Denmark
        • Finland
        • Iceland
        • Sweden
        • Norway
      • Benelux Union
        • Belgium
        • The Netherlands
        • Luxembourg
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • New Zealand
      • Australia
      • South Korea
      • Southeast Asia
        • Indonesia
        • Thailand
        • Malaysia
        • Singapore
        • Rest of Southeast Asia
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Kuwait
      • South Africa
      • Rest of Middle East & Africa
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America

Browse more trending reports by Absolute Markets Insights:

  • Point Of Care (POC) Diagnostic Devices Market – Global point of care (POC) diagnostic devices market is anticipated to clock a compound annual growth rate of 9.1% over the forecast period
  • Pocket Size Ultrasound Devices Market – Global pocket size ultrasound devices market was valued at US$ 115 Mn in 2020 and is anticipated to witness a CAGR of 10.34% over the forecast period and reach US$ 492 Mn by 2029
  • Digital Pathology Market – Global digital pathology market generated a revenue of US$ 823.38 Mn in 2020 and is estimated to grow at a CAGR of 10.1% over the forecast period.
  • Virtual Diagnostic Market – Global virtual diagnostic market is estimated to grow at a CAGR of 16.71% during the forecast period and reach $1409.57 Mn by 2028
  • Industrial Adhesives Market – Global industrial adhesives market was valued at $52.69 in 2020 and is projected to grow at a CAGR of 5.7% during the forecast period 2021 – 2029
  • Wearable Blood Pressure Sensor Market – Global wearable blood pressure sensor market is growing at a CAGR of 16.81% over the forecast period 2021 – 2029

Glance through Absolute Markets Insights plethora of reports on healthcare category.

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email ID: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com

SOURCE Absolute Markets Insights

.

About the author

Publishing Team